New Issue: Bank of Montreal prices $742,000 19.15% reverse exchangeables on Vertex

By Jennifer Chiou

New York, April 19 - Bank of Montreal priced $742,000 of 19.15% annualized reverse exchangeable notes due July 15, 2011 linked to the common stock of Vertex Pharmaceuticals Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Interest is payable monthly.

The payout at maturity will be par unless Vertex shares close below the trigger price - 75% of the initial share price - during the life of the notes and the final share price is less than the initial share price, in which case the payout will be a number of Vertex shares equal to $1,000 divided by the initial share price or, at the issuer's option, the cash value of those shares.

BMO Capital Markets Corp. is the agent.

Issuer:	Bank of Montreal
Issue:	Reverse exchangeable notes
Underlying stock:	Vertex Pharmaceuticals Inc. (Symbol: VRTX)
Amount:	$742,000
Maturity date:	July 15, 2011
Coupon:	19.15%, payable monthly
Price:	Par
Payout at maturity:	Par unless Vertex shares fall below 75% of initial share price during life of notes and finish below initial share price, in which case number of Vertex shares equal to $1,000 divided by initial share price or value of those shares in cash
Initial price:	$48.02
Trigger price:	$36.02, 75% of initial
Pricing date:	April 15
Settlement date:	April 20
Agent:	BMO Capital Markets Corp.
Fees:	2%
Cusip:	06366QFB8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.